Investor Relations

Investor Presentation
Overview
Specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension.
Investor Alerts
Receive updates straight to your inbox.
Sign Up Today
Latest News
View All Press Releases
Stock Quote

NASDAQ: TENX

View Stock Chart
IR cONTACT
John Mullaly
Managing Director
LifeSci Advisors, LLC
C: 617-429-3548
jmullaly@lifesciadvisors.com

Tenax Therapeutics

Specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension.